ArticleBreast cancer research : BCR2020

Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer.

Brooke N McKnight et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.